Didier Raoult
Didier Raoult
IHU Méditerranée Infection, Aix Marseille Université, AP-HM CHU Timone, Marseille, FRANCE
Adresse e-mail validée de univ-amu.fr
Titre
Citée par
Citée par
Année
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
P Gautret, JC Lagier, P Parola, L Meddeb, M Mailhe, B Doudier, J Courjon, ...
International journal of antimicrobial agents, 105949, 2020
35522020
Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry
P Seng, M Drancourt, F Gouriet, B La Scola, PE Fournier, JM Rolain, ...
Clinical Infectious Diseases 49 (4), 543-551, 2009
17742009
Q fever
M Maurin, D Raoult
Clinical Microbiology Review 12 (4), 518-553, 1999
17401999
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, ...
Science 359 (6371), 91-97, 2018
16942018
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
M Vétizou, JM Pitt, R Daillère, P Lepage, N Waldschmitt, C Flament, ...
Science 350 (6264), 1079-1084, 2015
15262015
16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates
M Drancourt, C Bollet, A Carlioz, R Martelin, JP Gayral, D Raoult
Journal of clinical microbiology 38 (10), 3623-3630, 2000
12322000
Ticks and tickborne bacterial diseases in humans: an emerging infectious threat
P Parola, D Raoult
Clinical infectious diseases 32 (6), 897-928, 2001
12092001
Tick-borne rickettsioses around the world: emerging diseases challenging old concepts
P Parola, CD Paddock, D Raoult
Clinical microbiology reviews 18 (4), 719-756, 2005
11322005
Microorganisms resistant to free-living amoebae
G Greub, D Raoult
Clinical microbiology reviews 17 (2), 413-433, 2004
10452004
Rickettsioses as paradigms of new or emerging infectious diseases.
D Raoult, V Roux
Clinical microbiology reviews 10 (4), 694-719, 1997
10221997
The 1.2-megabase genome sequence of Mimivirus
D Raoult, S Audic, C Robert, C Abergel, P Renesto, H Ogata, B La Scola, ...
Science 306 (5700), 1344-1350, 2004
9862004
Update on tick-borne rickettsioses around the world: a geographic approach
P Parola, CD Paddock, C Socolovschi, MB Labruna, O Mediannikov, ...
Clinical microbiology reviews 26 (4), 657-702, 2013
8952013
Comparative genomics of multidrug resistance in Acinetobacter baumannii
PE Fournier, D Vallenet, V Barbe, S Audic, H Ogata, L Poirel, H Richet, ...
PLoS genet 2 (1), e7, 2006
8612006
Microbial culturomics: paradigm shift in the human gut microbiome study
JC Lagier, F Armougom, M Million, P Hugon, I Pagnier, C Robert, F Bittar, ...
Clinical Microbiology and Infection 18 (12), 1185-1193, 2012
8322012
Endocarditis due to rare and fastidious bacteria.
P Brouqui, D Raoult
Clin Microbiol Rev 14 (1), 177-207, 2001
8082001
Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients
F Armougom, M Henry, B Vialettes, D Raccah, D Raoult
PloS one 4 (9), e7125, 2009
7642009
A giant virus in amoebae
B La Scola, S Audic, C Robert, L Jungang, X de Lamballerie, M Drancourt, ...
Science 299 (5615), 2033, 2003
7522003
Natural history and pathophysiology of Q fever
D Raoult, T Marrie, JL Mege
Lancet Infect Dis 5 (4), 219-226, 2005
7332005
The abundance and variety of carbohydrate-active enzymes in the human gut microbiota
A El Kaoutari, F Armougom, JI Gordon, D Raoult, B Henrissat
Nature Reviews Microbiology 11 (7), 497-504, 2013
7202013
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
CA Devaux, JM Rolain, P Colson, D Raoult
International journal of antimicrobial agents, 105938, 2020
7142020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20